ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MRKR Marker Therapeutics Inc

4.10
0.05 (1.23%)
Last Updated: 09:15:51
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Marker Therapeutics Inc MRKR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 1.23% 4.10 09:15:51
Open Price Low Price High Price Close Price Previous Close
4.05 4.05 4.15 4.05
more quote information »

Recent News

Date Time Source Heading
4/08/202406:00GLOBEPrincipal Investigator from City of Hope National Medical..
3/25/202416:45GLOBEMarker Therapeutics Reports Year-End 2023 Corporate and..
3/22/202411:30GLOBEMarker Therapeutics to Present at the H.C. Wainwright 2nd..
3/01/202407:02EDGAR2Form 8-K - Current report
2/26/202406:58EDGAR2Form 8-K - Current report
1/22/202406:30GLOBEMarker Therapeutics Receives Approval from United States..
1/08/202407:30EDGAR2Form 8-K - Current report
1/08/202407:24GLOBEMarker Therapeutics Announces Clinical Program Updates and..
12/21/202310:00GLOBEMarker Therapeutics Announces Participation in Biotech..
12/11/202306:35EDGAR2Form 8-K - Current report
12/11/202306:00GLOBEMarker Therapeutics Announces Sustained Complete Response in..
11/20/202315:37EDGAR2Form 8-K - Current report
11/09/202316:03EDGAR2Form 8-K - Current report
11/09/202316:00GLOBEMarker Therapeutics Reports Third Quarter 2023 Financial..
11/09/202315:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
9/11/202306:10EDGAR2Form 8-K - Current report
9/11/202306:00GLOBEMarker Therapeutics Announces Complete Response in First..
8/30/202307:00GLOBEMarker Therapeutics to Present at the H.C. Wainwright 25th..
8/14/202315:37EDGAR2Form 8-K - Current report
8/14/202315:30GLOBEMarker Therapeutics Reports Second Quarter 2023 Financial..
8/14/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202306:22EDGAR2Form 8-K - Current report
8/07/202306:00GLOBEMarker Therapeutics Reports Non-Clinical Proof-of-Concept..
7/26/202306:00GLOBEMarker Therapeutics to Participate in Virtual Roundtable..
7/10/202306:09EDGAR2Form 8-K - Current report
7/10/202306:00GLOBEEuropean Medicines Agency Grants Orphan Drug Designation for..
7/05/202315:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
7/03/202315:05EDGAR2Form 8-K - Current report
6/30/202315:05EDGAR2Form 8-K - Current report
6/26/202306:00GLOBEMarker Therapeutics Reports MT-401 Non-Clinical Data in AML..
6/12/202306:00GLOBEMarker Therapeutics Announces First Lymphoma Patient Treated..
5/31/202305:30GLOBEMarker Therapeutics Reports Pre-Clinical Data of its MT-601..
5/08/202306:30GLOBEMarker Therapeutics Appoints Monic Stuart, M.D., as Chief..

Your Recent History

Delayed Upgrade Clock